clinical trial · NCT06733688
A Study to Evaluate Oral Formulations of Tedizolid Phosphate in Healthy Participants (MK-1986-043)
Merck Sharp & Dohme LLC·phase1·completed·n = 36
HealthyTedizolid Phosphate Oral Formulation 1 (Reference)Tedizolid Phosphate Oral Formulation 2 (Test)
brief summary
The goal of the study is to learn what happens to different oral formulations of tedizolid phosphate (MK-1986) in a healthy person's body over time. Researchers want to know if there is a difference in the absorption and elimination of different oral formulations from the healthy person's body.
started
Mar 23, 2022
primary completion
Apr 15, 2022
completion
Apr 15, 2022
last updated
Dec 13, 2024
official title
A Study to Evaluate the Pharmacokinetics and Definitive Bioequivalence of Tedizolid Phosphate Single Unit Dose Sachet Powder for Oral Suspension Compared to Tedizolid Phosphate Multiple Dose Bottle Powder for Oral Suspension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol